BioSpace News Archive

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30.

Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced financial results for the fourth quarter and fiscal year ended December 31, 2019 and provided a business update.

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announced that a pre-emergency use authorization (EUA) application for NUZYRA• (omadacycline) has been submitted to the U.S. Food and Drug Administration (FDA).

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its financial results for the fourth quarter and twelve months ended December 31, 2019.

Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that David H. Donabedian, Ph.D., Co-founder and Chief Executive Officer of Axial Biotherapeutics will present a virtual company overview a

Copyright Clearance Center, Inc., a leader in advancing copyright, accelerating knowledge, and powering innovation, hosted an “Ask the Experts” program with MassBio, a not-for-profit organization that represents and provides services and support for the world’s leading life sciences supercluster.

Vuzix technology solutions provide efficient and effective alternative to corporate travel and site visits

Nine out of Fifteen Biopharma Companies Indicate Sales Reps are Beginning to Experience Access Issues, According to a New TGaS Advisory

Discovery Life Sciences™(Discovery), a global leader in biospecimen solutions, genomic, cell, and immunohistochemical (IHC) services, today announced the significant expansion of its cell biology and immunology services laboratory, specifically to accelerate discovery, preclinical, and clinical development of new cell therapies and immunotherapeutics.

HealthCare.com today released a study conducted to gauge American’s fears about the personal and financial risks of COVID-19, also known as the coronavirus.